Clarity Pharmaceuticals (ASX:CU6) Treats First Patient in Phase II SECuRE Trial
Clarity Pharmaceuticals (ASX:CU6) begins Phase II SECuRE trial with first patient treated and enhances 67Cu-SAR-bisPSMA formulation.
Tag: Corporate Strategy & Guidance
Buru Energy (ASX:BRU) Executes Strategic Development Agreement with CEFA
Buru Energy (ASX:BRU) signs a strategic agreement with CEFA for the Rafael Gas Project, advancing development and cashflow plans.
Accent Group Limited (ASX:AX1) Forms Strategic Partnership with Frasers Group
Accent Group (ASX:AX1) partners with Frasers Group to launch Sports Direct in Australia and New Zealand, expanding its retail presence.
4DMedical Limited (ASX:4DX) Converts Integral Diagnostics Pilot to Commercial Contract
4DMedical Limited (ASX:4DX) converts pilot program with Integral Diagnostics into a commercial contract, expanding lung imaging technology across Australia.
BetMakers Technology Group Limited (ASX:BET) Reports Q3 FY25 Financial Results
BetMakers Technology Group Limited (ASX:BET) reports a 3.7% QoQ revenue increase and improved gross margins in Q3 FY25.
Pacgold (ASX:PGO) Identifies Significant Geophysical Anomaly at White Lion Prospect
Pacgold (ASX:PGO) discovers a significant geophysical anomaly at White Lion Prospect, initiating plans for further surveys and drilling.
Australian Rare Earths Limited (ASX:AR3) Announces Expansion of Overland Project
Australian Rare Earths Limited (ASX:AR3) expands its Overland Uranium Project with 799 km² of new tenure, boosting exploration potential.
Visionflex Group Limited (ASX:VFX) Partners with Amplar Health for Virtual Nursing Project
Visionflex Group Limited (ASX:VFX) partners with Amplar Health to supply virtual care technology for aged care homes across Australia.
Netwealth Group Limited (ASX:NWL) Reports Funds Under Administration
Netwealth Group Limited (ASX:NWL) reported record Q1 funds under administration, showcasing significant growth and strong financial performance.
Nanoveu Limited (ASX:NVU) Appoints Scott Smyser to Accelerate Semiconductor Growth
Nanoveu Limited (ASX:NVU) appoints Scott Smyser as VP Sales and Marketing to drive semiconductor growth following the EMASS acquisition.